Two hundred and eighty-four patients with acute conjunctivitis were enrolled in a double-masked study comparing norfloxacin ophthalmic solution with placebo. The proportion of patients who were clinically improved after 5 days treatment was 88.1 % in the norfloxacin group and 71.6% in the placebo group (p<0.01). The proportion of patients who had all organisms eradicated, including the coagulase-negative staphylococci, after two to three days treatment was 52.7% for norfloxacin and 23.9% for placebo (p<0.01) and 64.7% and 26.3% (p<0.01) respectively when the coagulase-negative staphylococci were not included. Adverse experiences occurred in 4.2% of the patients receiving norfloxacin compared to 7.1% of the placebo patients. None of the adverse experiences was serious.
GigliottiF., HendleyJ.O., MorganJ., MichaelsR., DickensM., LohrJ.Efficacy of topical antibiotic therapy in acute conjunctivitis in children. Pediatric Pharmacol Therapeutics1984; 104: 623–6.
2.
ShunguD.L., TutlaneV.K., WeinbergE., GadebuschH.H.In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens. Chemother1985; 31: 112–8.
3.
GoldsteinE.J.G., CitronD.M., BendonL., VagvolgyiA.E., TrousdaleM.D., ApplebaumM.D.Potential of topical norfloxacin therapy. Comparative in vitro activity against clinical ocular bacterial isolates. Arch Ophthalmol1987; 105: 991–4.
4.
OsatoM.S., JensenH.G., TrousdaleM.D.The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am J Ophthalmol1989; 108: 380–6.
5.
JacobsonJ.A., CallN.B., KaswormE.M., DirksM.S., TurnerR.B.Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections. Antimicrob Agents Chemother1988; 32: 1820–4.
6.
MillerI.M., WittreichJ.M., CookT.J., VogelR. and The Norfloxacin-Chloramphenicol Ocular Study Group. The safety and efficacy of topical norfloxacin compared with chloramphenicol for the treatment of external ocular bacterial infections. Eye1992; 6: 111–4.
7.
CagleG.D., AbshireR.L.Quantitative ocular bacteriology: a method for the enumeration and identification of bacteria from the skin-lash margin and conjunctiva. Invest Ophthalmol Vis Sci1981; 20: 751–7.
8.
MantelN., HaenszelW.Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst1959; 22: 719–48.
9.
MantelN.Chi-square tests with one degree of freedom. Extensions of the Mantel-Haenszel procedure, 1963; 58: 690–700.
10.
FleissJ.L.Statistical methods for rates and proportions, New York: John Wiley and Sons, 1963; 160–8.
11.
BlythC.R., StillH.A.Binomial confidence intervals. J Am Stat Assoc1983; 78: 108–16.
12.
BadianiD., BronA., ElkingtonA.Use of a novel transport method for the quantification of the normal flora of the external eye. Microb Ecology Health Dis1988; 1: 57–9.
13.
CagleG., DavisS., RosenthalA., SmithJ.Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: a multicenter study. Curr Eye Res1981/1982; 1: 523–34.
14.
GibsonJ.R.Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bacterial conjuc-tivitis — A multicentre trial of its efficacy versus neomycin-polymyxin B-gramicidin and chloramphenicol ophthalmic solutions. J Antimicrob Chemother1983; 11: 217–21.
15.
MahajanV.M.Acute bacterial infections of the eye: their aetiology and treatment. Br J Ophthalmol1983; 67: 191–4.
16.
Behrens-BaumannW., QuentinC.D., GibsonJ.R., CalthropJ.G., HarveyS.G., BoothK.Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment. Curr Med Res Opinion1988; 11: 227–31.
17.
The Trimethoprim-Polymyxin B Sulphate Opthalmic Ointment Study Group. Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis — a review of four clinical studies. J Antimicrob Chemother1989; 23: 261–6.
